Inhibition of CMTM4 Sensitizes Cholangiocarcinoma and Hepatocellular Carcinoma to T Cell-Mediated Antitumor Immunity Through PD-L1.

Hepatol Commun · 2022 · PMC8710793 · PMID 34558800

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

HCC tumors derived from Hepa1‐6‐shCmtm4‐2 cells were significantly smaller in size compared with control, although shCmtm4‐1 did not reach statistical significance (Fig. 4B ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.